Newron Pharmaceuticals S.p.A. (SWX:NWRN)
18.30
-0.38 (-2.03%)
Mar 5, 2026, 5:31 PM CET
101.99% (1Y)
| Market Cap | 379.89M |
| Revenue (ttm) | 55.93M |
| Net Income (ttm) | 23.65M |
| Shares Out | 20.76M |
| EPS (ttm) | 1.11 |
| PE Ratio | 16.46 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 68,663 |
| Average Volume | 93,847 |
| Open | 18.54 |
| Previous Close | 18.68 |
| Day's Range | 18.16 - 19.12 |
| 52-Week Range | 5.20 - 31.85 |
| Beta | 0.66 |
| RSI | 38.18 |
| Earnings Date | Mar 24, 2026 |